AAP
Arax Advisory Partners Portfolio holdings
AUM
$2.18B
1-Year Return
13.41%
This Quarter Return
+0.61%
1 Year Return
+13.41%
3 Year Return
+43.76%
5 Year Return
–
10 Year Return
–
AUM
$1.03B
AUM Growth
+$77.4M
(+8.2%)
Cap. Flow
+$77.4M
Cap. Flow
% of AUM
7.55%
Top 10 Holdings %
Top 10 Hldgs %
30.42%
Holding
2,587
New
1,275
Increased
789
Reduced
244
Closed
48
Top Buys
| 1 |
iShares National Muni Bond ETF
MUB
|
+$19M |
| 2 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$3.25M |
| 3 |
NVIDIA
NVDA
|
+$2.82M |
| 4 |
Microsoft
MSFT
|
+$2.66M |
| 5 |
Vanguard Small-Cap Value ETF
VBR
|
+$1.84M |
Top Sells
| 1 |
Vanguard Small-Cap Growth ETF
VBK
|
+$1.78M |
| 2 |
iShares Russell Mid-Cap Growth ETF
IWP
|
+$1.69M |
| 3 |
Sterling Capital Focus Equity ETF
LCG
|
+$924K |
| 4 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$902K |
| 5 |
iShares Russell 2000 Value ETF
IWN
|
+$675K |
Sector Composition
| 1 | Technology | 5.63% |
| 2 | Healthcare | 2.97% |
| 3 | Financials | 2.79% |
| 4 | Consumer Discretionary | 2.28% |
| 5 | Industrials | 2.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
BridgeBio Pharma
BBIO
$9.74B
| $1.29K | ﹤0.01% |
+51
| New | +$1.29K |
|
2102
Allient
ALNT
$787M
| $1.29K | ﹤0.01% |
+51
| New | +$1.29K |
|
2103
Pioneer Bancorp
PBFS
$338M
| $1.27K | ﹤0.01% |
+127
| New | +$1.27K |
|
2104
Mineralys Therapeutics
MLYS
$2.73B
| $1.26K | ﹤0.01% |
+108
| New | +$1.26K |
|
2105
Alerus Financial
ALRS
$576M
| $1.26K | ﹤0.01% |
+64
| New | +$1.26K |
|
2106
Axogen
AXGN
$749M
| $1.25K | ﹤0.01% |
+173
| New | +$1.25K |
|
2107
Myriad Genetics
MYGN
$671M
| $1.25K | ﹤0.01% |
+51
| New | +$1.25K |
|
2108
Bluerock Homes Trust
BHM
$49.9M
| $1.24K | ﹤0.01% |
71
| – | – |
|
2109
Couchbase
BASE
$1.35B
| $1.24K | ﹤0.01% |
+68
| New | +$1.24K |
|
2110
Booz Allen Hamilton
BAH
$12.7B
| $1.23K | ﹤0.01% |
8
+6
| +300% | +$924 |
|
2111
Interpublic Group of Companies
IPG
$9.63B
| $1.22K | ﹤0.01% |
+42
| New | +$1.22K |
|
2112
MYR Group
MYRG
$2.73B
| $1.22K | ﹤0.01% |
+9
| New | +$1.22K |
|
2113
PepGen
PEPG
$49.5M
| $1.21K | ﹤0.01% |
+76
| New | +$1.21K |
|
2114
Aurora
AUR
$10.9B
| $1.21K | ﹤0.01% |
+436
| New | +$1.21K |
|
2115
Insmed
INSM
$30B
| $1.21K | ﹤0.01% |
18
-7
| -28% | -$469 |
|
2116
Nkarta
NKTX
$141M
| $1.21K | ﹤0.01% |
+204
| New | +$1.21K |
|
2117
Revolution Medicines
RVMD
$8.6B
| $1.2K | ﹤0.01% |
+31
| New | +$1.2K |
|
2118
Pacira BioSciences
PCRX
$1.23B
| $1.2K | ﹤0.01% |
+42
| New | +$1.2K |
|
2119
Privia Health
PRVA
$2.75B
| $1.2K | ﹤0.01% |
+69
| New | +$1.2K |
|
2120
StepStone Group
STEP
$4.88B
| $1.19K | ﹤0.01% |
+26
| New | +$1.19K |
|
|
AXDX
2121
DELISTED
Accelerate Diagnostics
AXDX
| $1.17K | ﹤0.01% |
1,000
| – | – |
|
2122
SPDR Portfolio Emerging Markets ETF
SPEM
$13.7B
| $1.17K | ﹤0.01% |
31
| – | – |
|
2123
Kayne Anderson Energy Infrastructure Fund
KYN
$2.05B
| $1.16K | ﹤0.01% |
113
+3
| +3% | +$31 |
|
2124
AGCO
AGCO
$8.13B
| $1.16K | ﹤0.01% |
12
-6
| -33% | -$581 |
|
|
MAGN
2125
Magnera Corporation
MAGN
$387M
| $1.16K | ﹤0.01% |
+64
| New | +$1.16K |
|